Filing Details
- Accession Number:
- 0001593968-22-000886
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-21 19:04:30
- Reporting Period:
- 2022-04-19
- Accepted Time:
- 2022-04-21 19:04:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1771917 | Karuna Therapeutics Inc. | KRTX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1579829 | A. Troy Ignelzi | C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-04-19 | 3,500 | $9.20 | 28,470 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-19 | 3,500 | $130.81 | 24,970 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-20 | 704 | $9.20 | 25,674 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-20 | 704 | $133.20 | 24,970 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-04-21 | 40 | $9.20 | 25,010 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-04-21 | 40 | $134.46 | 24,970 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (right to buy) | Disposition | 2022-04-19 | 3,500 | $0.00 | 3,500 | $9.20 |
| Common Stock | Option (right to buy) | Disposition | 2022-04-20 | 704 | $0.00 | 704 | $9.20 |
| Common Stock | Option (right to buy) | Disposition | 2022-04-21 | 40 | $0.00 | 40 | $9.20 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 155,356 | 2029-03-21 | No | 4 | M | Direct | |
| 154,652 | 2029-03-21 | No | 4 | M | Direct | |
| 154,612 | 2029-03-21 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $130.78 to $130.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter.
Billionaire Hedge Funds
